Month: October 2021

In this article MRK A nurse tends to a Covid-19 patient at SSM Health St. Anthony Hospital in Oklahoma City, August 24, 2021. Nick Oxford | Reuters Merck and Ridgeback Biotherapeutics plan to seek emergency authorization for their oral antiviral treatment for Covid-19, after the medicine showed “compelling results” in clinical trials. The drug, molnupiravir,
0 Comments